Edition:
India

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

2.84USD
16 Jul 2018
Change (% chg)

$0.13 (+4.80%)
Prev Close
$2.71
Open
$2.63
Day's High
$2.84
Day's Low
$2.63
Volume
10,907
Avg. Vol
30,538
52-wk High
$3.70
52-wk Low
$1.35

Chart for

About

Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon... (more)

Overall

Beta: --
Market Cap(Mil.): $23.39
Shares Outstanding(Mil.): 9.58
Dividend: --
Yield (%): --

Financials

BRIEF-Soleno Therapeutics Reports Q4 Loss Per Share $0.43

* Q4 LOSS PER SHARE $0.39 FROM CONTINUING OPERATIONS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

02 Apr 2018

BRIEF-Soleno Therapeutics Announces Successful End-Of-Phase II Meeting With FDA For DCCR In Prader-Willi Syndrome

* SOLENO THERAPEUTICS ANNOUNCES SUCCESSFUL END-OF-PHASE II MEETING WITH FDA FOR DCCR IN PRADER-WILLI SYNDROME

20 Feb 2018

BRIEF-Soleno Therapeutics Files For Resale Of Up To 14.2 Mln Shares

* SOLENO THERAPEUTICS INC FILES FOR RESALE OF UP TO 14.2 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (http://bit.ly/2DKTA0l) Further company coverage:

30 Jan 2018

Earnings vs. Estimates